Solitary Plasmacytoma of the Oral Cavity with Review of Literature: A Case Report
Journal: International Journal of Dentistry and Oral Science (IJDOS) (Vol.08, No. 09)Publication Date: 2021-09-03
Authors : Shivananda S Vidya G Doddawad Manjula S Aruna G Muni Sekhar;
Page : 4337-4340
Keywords : Lymphoproliferative Disorder; Mandible; Maxillofacial; Plasma Cell Tumor; Plasmacytoma; Solitary Bone;
Abstract
Solitary bone plasmacytoma is considered as a3% of all plasma cell containing tumors anduncommon condition in the head and neck region especially in the jaws which demonstrate as a single bone tumor.Based on clinical behavior and prognosis, multiple myeloma is differing from the solitary plasmacytoma. The incidence rate of localized plasmacytoma is lesser than the multiple myeloma.However, localised bone plasmacytoma is less commonly manifest among plasma cell tumour. Only 3% of Solitary bone plasmacytoma is a plasma cell tumor and considered as an immunoproliferative monoclonal disease. Localized plasmacytoma are rare in occurrence than multiple myeloma andappear as a single and extra osseous form of bone neoplasm. Solitary bone plasmacytoma seen in the long bones, vertebrae, sternum,clavicle, rib and humerus are the most common sites, but rarely involves maxillofacial region. Here, we report a rare case of solitary plasmacytoma affecting a mandible which is diagnosed based on the clinical, radiological, hematological, and histopathological findings.
Other Latest Articles
- Effectiveness Of Metrogyl, Chlorhexidine And Betadine As An Irrigant During Surgical Extraction Of Impacted Mandibular 3rd Molars
- A Winding Journey In The Nomenclature Of Odontogenic Keratocyst and a Revisit of the Four Editions Of The WHO Classification On Odontogenic Cyst And Tumours
- The Role of Herbs in Influencing Periodontal Health - A Systematic Review
- Assessment of Relation and Course of Inferior Alveolar Nerve Using CBCT-A Retrospective Study of 120 Cases
- Effectiveness Of Lidocaine Gel Vs Lidocaine Spray As A Topical Anaesthetic Agent Before Inferior Alveolar Nerve Block
Last modified: 2021-11-03 15:01:33